Select Page

New and changed data collection on TIEDI coming Aug. 30

New and changed data collection on TIEDI coming Aug. 30


  • Transplant hospital coordinators, data coordinators, quality coordinators, administrators and directors who update and validate the following TIEDI® forms:
    • Transplant Recipient Registration form (TRR)
    • Pediatric Transplant Recipient Follow-Up (TRF)
    • Pediatric Transplant Candidate Registration (TCR)
    • Liver Transplant Candidate Registration (TCR)
    • Liver Recipient Explant Pathology Form (LIEX)

Implementation date

Aug. 30, 2022


Several policy changes impacting TIEDI forms were approved by the Office of Management and Budget (OMB) in March 2022. These policies are:

Data collection changes related to these policies include:

  • All Transplant Recipient Registration forms (TRR)
    • The OPTN does not currently collect data on the HBV vaccination status of an organ recipient.
    • With the change in policy, members will be required to assess the need to provide HBV vaccination and report candidate’s HBV vaccination status to the OPTN prior to transplant on the TRR.
  • Pediatric Transplant Recipient Registration forms (TRR), Pediatric Transplant Candidate Registration forms (TCR), 1 and 5 year Pediatric Transplant Recipient Follow Up forms (TRF)
    • Currently the OPTN collects a singular Date of Measurement for Height and Weight.
    • Height Date of Measurement and Weight Date of Measurement will be collected separately.
  • Liver Transplant Recipient Registration form (TRR) and Liver Transplant Candidate Registration form (TCR)
    • Currently, options for Alcohol-Associated Primary and Secondary Diagnoses include “Alcoholic Cirrhosis” and “Acute Alcoholic Hepatitis.”
    • With the policy change, these options will be replaced by “Alcohol-associated cirrhosis without acute alcohol-associated hepatitis” and “Acute alcohol-associated hepatitis with or without cirrhosis.”
    • A third diagnosis, “Alcoholic Cirrhosis with Hepatitis C,” will be inactivated.
  • Liver Recipient Explant Pathology Form (LIEX)
    • Currently, under Clinical Information the OPTN collects data on if a candidate received “Pre-transplant treatment for HCC.”
    • With the policy change, the question will be clarified to read “Did recipient receive any pre-transplant liver-directed therapy for HCC?” The meaning and purpose of this question will not change.
    • If a response of No is reported for both questions, “Was evidence of HCC (viable or non-viable tumor) found in the explant?” and “Did recipient receive any pre-transplant liver-directed therapy for HCC?” Then a notification will be displayed reminding the member to submit supporting documentation of the patient’s HCC diagnosis at the time of assignment.

What you need to do

No actions will be required of members to view the new and changed data collection in TIEDI. Members who are responsible for completing these forms will need to begin completing them in compliance with policy starting on Aug. 30, 2022. Members should begin making preparations to:

  • Report HBV vaccination status on the TRR
  • Report separate dates of measurement for both height and weight on all pediatric forms in TIEDI


If you have questions relating to implementation, contact UNOS Customer Service at [email protected], or call 800-978-4334 from 8 a.m. to 7 p.m. ET

For policy-related questions, contact [email protected]

Share This